29.4 C
Delhi
Saturday, July 12, 2025

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

Share post:

Donate-GC-Razorpay

Los Angeles: Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

Related articles

Confidence of New India Will Lead to Viksit Bharat: ‘Viksit Bharat: India @ 2047’ Author Aditya Pittie

Timely and meticulously researched, ‘Viksit Bharat: India @ 2047’, by author and thought leader, Aditya Pittie, provides a...

Voice of a Nation, Voice of the World: PM Modi’s Historic Addresses to Foreign Parliaments

An Unprecedented Journey of Words and WillIn the grand halls of parliaments across continents, where voices echo...

The Emerging Axis: Turkiye-Pakistan Bonhomie and Its Implications for India

The Ankara-Islamabad TangoIn the simmering July heat of Islamabad, the red carpet was rolled out for two...

SSI MantraM “Made in India” Surgical Robot Yatra Kicks Off India Tour, First Leg to Cover 1500 km Across Rajasthan

 ● In the first phase of the roadshow, SSI MantraM will cover key medical institutions across Jaipur, Jodhpur,...